Search
for
Sort by
Research 121–150 of 274
- Effect of Marine-Derived Saccharides on Human Skin Fibroblasts and Dermal Papilla Cells
- Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review
- Polycystic ovary syndrome and iron overload: biochemical link and underlying mechanisms with potential novel therapeutic avenues
- Food and medicine homology: a potential nutritional intervention strategy for post-acute COVID-19 syndrome
- A Comprehensive Review on Nutrient Profile and Pharmacological Benefits of Musa paradisiaca
- Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Association of Polish Surgeons, and the College of Family Physicians in Poland
- The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review
- The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- The Influence of Monosaccharide Composition on the Bioactivity of Medicinal Plant Polysaccharides
- Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease
- Use of Myoinositol in PCOS
- Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review
- Insulin resistance as risk factor for the development of type 2 diabetes mellitus: a systematic approach
- Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches
- Mechanisms of Impaired Skeletal Muscle Regeneration and Therapeutic Approaches in Aging and Chronic Disease
- Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- GLP-1 e Estética: Ozempic Face, Flacidez e Recuperação
- Nonscarring Alopecia in Adults Treated With GLP ‐1s: A Propensity Score Matched TriNetX Cohort Study
- 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review
- 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization
- Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia
- GLP‐1 agonists and hair loss: a call for further investigation
- A Systematic Review of the Cutaneous Adverse Effects of GLP-1 Agonists
- Hair and Scalp Effects of GLP-1 Receptor Agonists in Practice
- Increased risk of hair loss with GLP-1 receptor agonists: A real-world multicenter TrinetX cohort study
- Glucagon-like peptide-1 receptor and proglucagon expression in mouse skin
- Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study